Rhodiola Rosea for Coronary Microvascular Disease

Summary

To investigate the effects of rhodiola rosea on coronary flow reserve and symptoms in patients with microvascular angina pectoris, and to evaluate adverse drug reactions. Long-term clinical follow-up of 1 to 3 years was conducted to evaluate the effect of rhodiola rosea on long-term adverse cardiovascular events in patients with coronary microvascular disease.

Timeline

Start

2020-01

Primary completion

2021-01

Completion

2023-01

Drugs

Indications